Abvc Biopharma, Inc. SEC filings ABVC
Abvc Biopharma, Inc. has 795 filings in SEC EDGAR's recent list, going back to Jun 28, 2002. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement, agreement ended, new debt, unregistered share sale, shareholder vote results, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Sep 29, 2026 | Oct 28, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 28, 2026 | Jul 28, 2026 |
| DEF 14A | Proxy statement | Mar 5, 2026 | Mar 26, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 5, 2026 | Feb 5, 2026 |
| DEF 14A | Proxy statement | May 16, 2025 | Jun 3, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 25, 2025 | Apr 24, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| DEFA14A | Additional proxy material | Mar 25, 2024 | — |
| DEFA14A | Additional proxy material | Mar 14, 2024 | — |
| DEF 14A | Proxy statement | Dec 29, 2023 | Jan 16, 2024 |
| PRE 14A | Preliminary proxy statement | Dec 15, 2023 | Dec 15, 2023 |
| DEF 14A | Proxy statement | Jun 21, 2023 | Jul 7, 2023 |
| PRE 14A | Preliminary proxy statement | May 31, 2023 | May 31, 2023 |
| DEF 14A | Proxy statement | Apr 14, 2023 | Apr 24, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2023 | Apr 3, 2023 |
| DEF 14A | Proxy statement | Apr 27, 2022 | May 20, 2022 |
| DEF 14A | Proxy statement | Jan 20, 2011 | Jan 20, 2011 |
| PREM14A | Preliminary proxy | Jan 11, 2011 | Jan 10, 2011 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABVC (Nasdaq), ECOC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fremont, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1173313
- Former names
- American BriVision (Holding) Corp (until Apr 8, 2021); METU BRANDS, INC. (until Jan 8, 2016); Ecology Coatings, Inc. (until Sep 2, 2015); ECOLOGY COATINGS, INC. (until Sep 2, 2015); OCIS CORP (until Jun 13, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.